ea0029p1488 | Pituitary Clinical | ICEECE2012
Bernabeu I
, Alvarez-Escola C
, Paniagua A
, Lucas T
, Pavon I
, Cabezas Agricola J
, Casanueva F
, Marazuela M
Objective: Combination with cabergoline may offer additional benefits to acromegalic patients on pegvisomant monotherapy. We evaluated the safety and efficacy profile of this combination and investigated the determinants of response.Design: An observational, retrospective, cross-sectional, registry-based study.Patients and methods: Fourteen acromegalic patients (9 females), who were partially resistant to somatostatin analogs and o...